Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DRAM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EED - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2N - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOSC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTRHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLCO3A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNAS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FIBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIGMAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC44A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RYBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on